HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F Caponigro Selected Research

M-VAC protocol

6/2007Therapy of metastatic bladder carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F Caponigro Research Topics

Disease

12Neoplasms (Cancer)
01/2018 - 03/2000
5Colorectal Neoplasms (Colorectal Cancer)
01/2009 - 01/2001
4Squamous Cell Carcinoma of Head and Neck
11/2017 - 05/2000
3Head and Neck Neoplasms (Head and Neck Cancer)
03/2003 - 03/2000
2Exanthema (Rash)
01/2016 - 03/2003
2Pain (Aches)
01/2016 - 03/2003
2Fatigue
01/2016 - 07/2010
2Febrile Neutropenia
07/2010 - 03/2000
2Carcinoma (Carcinomatosis)
06/2007 - 05/2005
2Neutropenia
05/2000 - 03/2000
1Disease Progression
11/2017
1Diarrhea
01/2016
1Acne Vulgaris
01/2016
1Stomatitis
01/2016
1Sarcoma (Soft Tissue Sarcoma)
07/2010
1Hematologic Neoplasms (Hematological Malignancy)
02/2009
1Multiple Myeloma
02/2009
1Melanoma (Melanoma, Malignant)
01/2005
1Asthenia
03/2003
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2003
1Rectal Neoplasms (Rectal Cancer)
07/2001
1Nausea
03/2000
1Thrombocytopenia (Thrombopenia)
03/2000
1Hemorrhage
03/2000
1Alopecia (Baldness)
03/2000

Drug/Important Bio-Agent (IBA)

6Cisplatin (Platino)FDA LinkGeneric
11/2017 - 05/2000
4Fluorouracil (Carac)FDA LinkGeneric
01/2009 - 05/2000
3ErbB Receptors (EGF Receptor)IBA
01/2018 - 05/2005
3Methotrexate (Mexate)FDA LinkGeneric
01/2016 - 03/2003
3raltitrexed (D 1694)IBA
07/2001 - 05/2000
3AcidsIBA
07/2001 - 05/2000
2Bortezomib (Velcade)FDA Link
02/2009 - 01/2009
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2009 - 07/2001
2Leucovorin (Folinic Acid)FDA Link
01/2009 - 02/2002
2GemcitabineFDA Link
06/2007 - 05/2005
2Doxorubicin (Adriamycin)FDA LinkGeneric
06/2007 - 03/2000
2Docetaxel (Taxotere)FDA Link
09/2005 - 02/2001
2TransferasesIBA
09/2005 - 05/2005
2acridine DACAIBA
02/2003 - 01/2002
1Paclitaxel (Taxol)FDA LinkGeneric
11/2017
1Cetuximab (Erbitux)FDA Link
11/2017
1AfatinibIBA
01/2016
1PlatinumIBA
01/2016
1brostallicinIBA
07/2010
1UbiquitinIBA
02/2009
1Proteasome InhibitorsIBA
02/2009
1Proteasome Endopeptidase Complex (Proteasome)IBA
02/2009
1Vinblastine (Vinblastine Sulfate)FDA Link
06/2007
1vinflunineIBA
06/2007
1Protein Isoforms (Isoforms)IBA
09/2005
1tipifarnib (R115777)IBA
09/2005
1Tyrosine (L-Tyrosine)FDA Link
05/2005
1Epidermal Growth Factor (EGF)IBA
05/2005
1LigandsIBA
05/2005
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2005
1Peptides (Polypeptides)IBA
05/2005
1Phosphotransferases (Kinase)IBA
05/2005
1Proteins (Proteins, Gene)FDA Link
05/2005
1lonafarnib (SCH 66336)IBA
05/2005
1N- (3- chloro- 7- indolyl)- 1,4- benzenedisulphonamide (E7070)IBA
01/2005
1olivacineIBA
03/2003
1NSC 659687IBA
03/2003
1Type I DNA Topoisomerases (Topoisomerase I)IBA
02/2003
1DNA (Deoxyribonucleic Acid)IBA
02/2003
1Cytotoxins (Cytolysins)IBA
02/2003
1Mitoxantrone (Novantrone)FDA LinkGeneric
01/2001
1Liposomes (Liposome)IBA
03/2000
1Drug CarriersIBA
03/2000
1liposomal doxorubicin (Doxil)FDA Link
03/2000

Therapy/Procedure

7Therapeutics
01/2018 - 07/2001
4Drug Therapy (Chemotherapy)
05/2005 - 03/2000
1Conservative Treatment
01/2018
1M-VAC protocol
06/2007
1Salvage Therapy
05/2005
1Radiotherapy
07/2001